Lindbrook Capital’s Covetrus, Inc. Common Stock CVET Stock Holding History

Lindbrook Capital’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-210	Closed	-$4K	–	3080
2022 Q3	$4K	Sell	210 -25	-11%	-$520	﹤0.01%	1823
2022 Q2	$5K	Buy	235 +91	+63%	+$1.62K	﹤0.01%	1595
2022 Q1	$2K	Buy	+144	New	+$2.52K	﹤0.01%	2137
2020 Q2	–	Sell	-92	Closed	-$1K	–	1935
2020 Q1	$1K	Buy	+92	New	+$1.05K	﹤0.01%	1630

Other funds holding CVET

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Lindbrook Capital's CVET Position: Q4 2022 in Review

Lindbrook Capital sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 210 shares — an estimated $4K sold.

Lindbrook Capital first reported a position in CVET in Q1 2020 and held it in 4 quarters. The position peaked at $5K in Q2 2022. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

Lindbrook Capital reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Lindbrook Capital sold 210 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $4K.
Lindbrook Capital first reported a position in Covetrus, Inc. Common Stock in Q1 2020 and held it in 4 quarters.
Lindbrook Capital's Covetrus, Inc. Common Stock position peaked at $5K in Q2 2022.
5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Lindbrook Capital's 13F filing for Q4 2022, filed 25 Jan 2023.